| Drug Name |
Risedronate sodium |
| Drug ID |
BADD_D01949 |
| Description |
Risedronic acid is a third generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label][A959,A203111]. It functions by preventing resorption of bone[FDA Label][A959]. |
| Indications and Usage |
For the treatment of Paget's disease of the bone (osteitis deformans), postmenopausal and glucocorticoid-induced osteoporosis |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
M05BA07 |
| DrugBank ID |
DB00884
|
| KEGG ID |
D00942
|
| MeSH ID |
D000068296
|
| PubChem ID |
4194514
|
| TTD Drug ID |
D0PA5S
|
| NDC Product Code |
65862-517; 0430-0979; 65977-0092; 33342-109; 60723-041; 70771-1436; 47335-667; 65372-1113; 16714-870; 47335-928; 63304-440; 59762-0407; 0093-3098; 0093-3100; 33342-107; 53104-7653; 65862-518; 0430-0478; 59762-0405; 14998-0008; 65096-0110; 0430-0473; 59762-0406; 65862-519; 47335-666; 47335-668; 11722-077; 65862-870; 0430-0472; 0430-0970; 68382-075; 80426-042; 47335-727; 0093-3099; 60505-3165; 60505-3097; 0430-0487; 62331-017; 33342-108; 60505-3096; 0093-7771 |
| Synonyms |
Risedronic Acid | 1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate | Atelvia | Risedronate Sodium | 2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate | 2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate | Risedronic Acid, Monosodium Salt | Actonel | Risedronate | Bisphosphonate Risedronate Sodium | Risedronate Sodium, Bisphosphonate | Sodium, Bisphosphonate Risedronate |
